---
title: "Adagio Medical Falls 8% in After-Hours Trading After Earlier FDA-Related Surge"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294863103.md"
description: "Adagio Medical (ADGM) fell in after-hours trading, pulling back from an August rally driven by positive vCLAS Ultra treatment news."
datetime: "2026-08-04T20:05:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294863103.md)
  - [en](https://longbridge.com/en/news/294863103.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294863103.md)
---

# Adagio Medical Falls 8% in After-Hours Trading After Earlier FDA-Related Surge

Adagio Medical(ADGM.US) 盘后跌 7.60%，现报 0.7424 美元。

消息面上，公司近日宣布在 FDA 扩大使用授权下，成功使用新一代 vCLAS Ultra 消融系统完成首例患者治疗。该程序在既往治疗失败的患者中取得成功，凸显了其在难治性病例中的应用潜力。临床前数据显示，单次冷冻设计可能缩短手术时间。公司还宣布 FDA 已批准将其 FULCRUM-VT 关键性试验扩展至该系统，并预计未来数月内将获得一代 ULTA 系统的批准。

此前在 8 月 4 日的美股交易时段中，该股曾出现大幅波动，盘前涨超 30%，盘中一度涨超 84%，当日收盘大涨 74.67% 至 0.8035 美元。此次盘后回调属于前期大涨后的正常波动。

### Related Stocks

- [ADGM.US](https://longbridge.com/en/quote/ADGM.US.md)

## Related News & Research

- [Adagio Medical treats first patient with next-generation vCLAS Ultra ULTA system under FDA expanded access](https://longbridge.com/en/news/294693443.md)
- [Adagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progress | ADGM Stock News](https://longbridge.com/en/news/286095782.md)
- [07:19 ETRéunissant la communauté mondiale des capitaux à Abou Dabi, l'ADFW 2026 dévoile sa première vague d'intervenants de premier plan](https://longbridge.com/en/news/295789052.md)
- [Adagio Medical submits PMA to FDA for vCLAS after 209‑patient FULCRUM‑VT trial](https://longbridge.com/en/news/287270290.md)
- [Adaigo Medical Receives FDA IDE Approval To Study Next-Generation VCLAS Ventricular Ablation System](https://longbridge.com/en/news/282050466.md)